N-(5-methylthiazol-2-yl)-4-((phenylamino)methyl)benzamide

ID: ALA4292656

PubChem CID: 145987660

Max Phase: Preclinical

Molecular Formula: C18H17N3OS

Molecular Weight: 323.42

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1csc(NC(=O)c2ccc(CNc3ccccc3)cc2)n1

Standard InChI:  InChI=1S/C18H17N3OS/c1-13-12-23-18(20-13)21-17(22)15-9-7-14(8-10-15)11-19-16-5-3-2-4-6-16/h2-10,12,19H,11H2,1H3,(H,20,21,22)

Standard InChI Key:  JAHPSHXIFCRWAV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   18.4886   -2.5877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4874   -3.4073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1955   -3.8162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9051   -3.4068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9023   -2.5841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1937   -2.1789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6085   -2.1729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3177   -2.5788    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6054   -1.3557    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7794   -3.8153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0720   -3.4062    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3640   -3.8142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6573   -3.4028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9498   -3.8102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9487   -4.6283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6611   -5.0373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3657   -4.6276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0239   -2.1675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7710   -2.4959    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.3155   -1.8866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9042   -1.1803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1056   -1.3534    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   24.1285   -1.9689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  7  9  2  0
  2 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  8 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 18  1  0
 20 23  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4292656

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 323.42

Molecular Weight (Monoisotopic): 323.1092

AlogP: 4.32

#Rotatable Bonds: 5

Polar Surface Area: 54.02

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 11.70

CX Basic pKa: 3.92

CX LogP: 3.74

CX LogD: 3.74

Aromatic Rings: 3

Heavy Atoms: 23

QED Weighted: 0.74

Np Likeness Score: -2.10

References

1. Iida T, Ubukata M, Mitani I, Nakagawa Y, Maeda K, Imai H, Ogoshi Y, Hotta T, Sakata S, Sano R, Morinaga H, Negoro T, Oshida S, Tanaka M, Inaba T..  (2018)  Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity.,  158  [PMID:30248655] [10.1016/j.ejmech.2018.09.003]

Source

Source(1):

• Scientific Literature